The Regenexx family ofnon-surgical stem cell and blood platelet procedures offer next-generation injection treatments for those who are suffering from knee pain or may be facing knee surgery or knee replacement due to common tendon, ligament and bone injuries, arthritis and other degenerative conditions.

As an alternative to knee surgery or knee replacement, Regenexx procedures may help alleviate knee pain and the conditions that cause it with a same-day office injection procedure. Unlike traditional surgery, Regenexx patients are typically encouraged to walk the same day, and most patients experience very little down time from the procedure.

This is not a complete list of conditions treated, but the most common knee conditions we have treated throughout the years. If you are experiencing knee pain, injury, or arthritis, please contact us or complete the candidacy form below to learn more about whether the Regenexx Procedures are right for you.

This Regenexx-SD (same-day) bone marrow derived stem cell treatment outcome data analysis is part of the Regenexx data download of patients who were tracked in the Regenexx advanced patient registry.

This Regenexx-SD (same-day) bone marrow derived stem cell treatment outcome data analysis is part of the Regenexx data download of patients who were tracked in the Regenexx advanced patient registry following treatment for Meniscus Tears.

This data utilizes LEFS (Lower Extremity Functional Scale) data from our knee arthritis patients treated with stem cell injections. Functional questionnaires ask the patients questions such as how well they can walk, run, climb stairs, etc. The improvements following the Regenexx-SD procedure are highly statistically significant.

If you are considering a knee replacement, watch the video in the sidebar of this page and read about how stem cells stack up against knee replacements.

Introduction. We investigated the use of autologous bone marrow concentrate (BMC) with and without an adipose graft, fortreatment of knee osteoarthritis (OA). Methods. Treatment registry data for patients who underwent BMC procedures with andwithout an adipose graft were analyzed. Pre- and posttreatment outcomes of interest included the lower extremity functional scale(LEFS), the numerical pain scale (NPS), and a subjective percentage improvement rating. Multivariate analyses were performedto examine the effects of treatment type adjusting for potential confounding factors. The frequency and type of adverse events(AE) were also examined. Results. 840 procedures were performed, 616 without and 224 with adipose graft. The mean LEFS scoreincreased by 7.9 and 9.8 in the two groups (out of 80), respectively, and the mean NPS score decreased from 4 to 2.6 and from 4.3to 3 in the two groups, respectively. AE rates were 6% and 8.9% in the two groups, respectively. Although pre- and posttreatmentimprovements were statistically significant, the differences between the groups were not. Conclusion. BMC injections for knee OAshowed encouraging outcomes and a low rate of AEs. Addition of an adipose graft to the BMC did not provide a detectible benefitover BMC alone.

Two time Super Bowl Champ Jarvis Greens story. From a young boy struggling to get through a football practice, to a 2X Super Bowl Champion, Jarvis tells his story of pain and struggle following knee surgeries, and his return to form following a Regenexx Stem Cell Procedure.

If you are interested in learning whether you are a good candidate for the Regenexx Procedure, please complete the Regenexx Procedure Candidate Form below or call us at 888-525-3005.